Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Boehringer Ingelheim
McKesson
Express Scripts
Mallinckrodt

Last Updated: October 1, 2022

CLINORIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Clinoril patents expire, and when can generic versions of Clinoril launch?

Clinoril is a drug marketed by Merck and is included in one NDA.

The generic ingredient in CLINORIL is sulindac. There are fourteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the sulindac profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Clinoril

A generic version of CLINORIL was approved as sulindac by WATSON LABS on April 3rd, 1990.

  Try it Free

Drug patent expirations by year for CLINORIL
Recent Clinical Trials for CLINORIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cancer Prevention Pharmaceuticals, Inc.Phase 3
Stony Brook UniversityPhase 2
Children's Oncology GroupPhase 2

See all CLINORIL clinical trials

US Patents and Regulatory Information for CLINORIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck CLINORIL sulindac TABLET;ORAL 017911-001 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Merck CLINORIL sulindac TABLET;ORAL 017911-002 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CLINORIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck CLINORIL sulindac TABLET;ORAL 017911-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Merck CLINORIL sulindac TABLET;ORAL 017911-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Merck CLINORIL sulindac TABLET;ORAL 017911-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Merck CLINORIL sulindac TABLET;ORAL 017911-001 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for CLINORIL

See the table below for patents covering CLINORIL around the world.

Country Patent Number Title Estimated Expiration
Poland 89133 See Plans and Pricing
Hungary 163007 See Plans and Pricing
Malaysia 7400082 SUBSTITUTED INDENYLACETIC ACIDS AND THEIR DERIVATIVES See Plans and Pricing
Poland 92148 See Plans and Pricing
Yugoslavia 34510 See Plans and Pricing
Hungary 165284 See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
Mallinckrodt
Merck
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.